Home Health Blood pressure medication recalled due to small amounts of carcinogenic substance

Blood pressure medication recalled due to small amounts of carcinogenic substance

Macleods Pharmaceuticals Limited remembers many losartan-potassium / hydrochlorothiazide combination tablets because they may contain a carcinogenic substance.

According to the

Website of the US Food and Drug Administration,

the tablets, with which hypertension and hypertensive patients are treated

left ventricular hypertrophy

, contained small amounts of N-nitrosodiethylamine (NDEA).

The 100 mg / 25 mg tablets that are recalled include:

NDC Manufacturer Product description Lot / Batch expiration date
33342-0052-10 Macleods Pharmaceuticals Limited Losartan Potassium / Hydrochlorothiazide combination tablets 100 mg / 25 mg, 90 count bottles BLM715A Jul-2019

"Patients using Losartan Potassium / Hydrochlorothiazide combination tablets should continue to take USP as the risk of damage to the patient's health may be greater if treatment is stopped immediately without alternative treatment," the FDA explains.

Anyone who has general questions about the return of this product should contact Qualanex via e-mail

recall@qualanex.com

or call 888-280-2042, 7 am to 4 pm, CST, from Monday to Friday.

To read the full release,

Click here.

.

Must Read

Meghan Markle's mother Doria Ragland arrives in London before the birth of Royal Baby

Meghan Markle's mother Doria Ragland arrives in London tonight before the birth of Royal Baby ...

Greta Thunberg received in London | TIME ONLINE

Climate activist Greta Thunberg has been acclaimed by the Extinction Rebellion Movement in London. She was greeted by hundreds of demonstrators, including "We love...

Marvel Movies: Before & # 39; Avengers: Endgame & # 39; looks back on Marvel's box-office hit

Marvel's avengers are back to save the world and the box office. "Avengers: Endgame" will be released in cinemas on...